Change in agreement regarding additional purchase consideration for Multiferon®June 29th, 2011
FiledJune 29th, 2011A new agreement has been signed regarding the additional purchase consideration for Multiferon and the hepatitis C clinical study which was included in the agreement with the sellers upon Biovitrum’s acquisition of Swedish Orphan 2009.